1. "Pediatrics, Department of"
Formats
  1. Journal Article (2874)
  2. Meeting Abstract (1908)
  3. Review (135)
  4. Book Section (123)
  5. Editorial (61)
  6. Conference Paper (53)
  7. Research Letter (33)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (11)
  11. Book Whole (4)
Groups
  1. Pediatrics, Department of (5250)
  2. Tow Center for Developmental Oncology (TCDO) (2073)
  3. GSK Faculty (1984)
  4. Center for Hematologic Malignancies (1906)
  5. Stem Cell Transplantation and Cellular Therapy Service (1636)
  6. Department of Medicine (1584)

More Groups

People
  1. Richard O'Reilly (748)
  2. Nai-Kong Cheung (648)
  3. Nancy Kernan (512)
  4. Michael La Quaglia (411)
  5. David Abramson (388)
  6. Ira Dunkel (371)

More People

Years
  1. 2025 (91)
  2. 2024 (231)
  3. 2023 (272)
  4. 2022 (332)
  5. 2021 (278)
  6. 2020 (323)

More Years

Publications
  1. Blood (608)
  2. Journal of Clinical Oncology (430)
  3. Pediatric Blood and Cancer (416)
  4. Biology of Blood and Marrow Transplantation (265)
  5. Neuro-Oncology (235)
  6. Cancer Research (129)

More Publications

Publishers
  1. American Society of Hematology (663)
  2. Elsevier Inc. (658)
  3. American Society of Clinical Oncology (463)
  4. Wiley Periodicals, Inc (430)
  5. Oxford University Press (338)
  6. American Association for Cancer Research (317)

More Publishers

Results (5250)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel reduced intensity conditioning can induce a high incidence of sustained donor engraftment after double unit cord blood transplantation (CBT) without anti-thymocyte globulin
    Meeting Abstract

    Ponce, D. M.; Sauter, C.; Lubin, M.; Gonzales, A. M.; Heller, G.; Castro-Malaspina, H.; Giralt, S.; Kernan, N. A.; Papadopoulos, E. B.; Scaradavou, A.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • T-Cell depletion is an alternative approach for patients >/=55 years undergoing allogeneic stem cell transplantation as curative therapy for hematologic diseases
    Meeting Abstract

    Petrlik, E.; Castro-Malaspina, H.; Boulad, F.; Papadopoulos, E.; Jakubowski, A. A.
    Blood (2010)

    Fulltext@MSK | Save
  • Pertussis response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) in recipients of allogeneic hematopoietic stem cell transplants (Allo HSCT)
    Meeting Abstract

    Papadopoulos, E.; Iovino, C. S.; Knowles, M.; Barker, J.; Scaradavou, A.; Kernan, N. A.; Small, T. N.
    Blood (2010)

    Fulltext@MSK | Save
  • Rituximab maintenance treatment in immune mediated thrombocytopenia (ITP) including Evans syndrome
    Meeting Abstract

    Mahler, M.; Hasan, A.; Bussel, J. B.
    Blood (2010)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation (HSCT) for pediatric patients with treatment related myelodysplastic syndrome or acute myelogenous leukemia (tMDS/AML)
    Meeting Abstract

    Kobos, R.; Steinherz, P. G.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Shukla, N.; Khalaf, R.; O'Reilly, R. J.; Boulad, F.
    Blood (2010)

    Fulltext@MSK | Save
  • Two-compartment pharmacokinetics model of radioimmunotherapy with I-131-3F8 directly administered into the cerebrospinal fluid
    Meeting Abstract

    He, P.; Kramer, K.; Smith-Jones, P.; Zanzonico, P.; Humm, J.; Larson, S. M.; Cheung, N. K. V.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Virus specific T-lymphocytes genetically modified to target the CD19 antigen eradicates systemic lymphoma in mice
    Meeting Abstract

    Curran, K. J.; Taylor, C.; Doubrovina, E.; Wang, X.; O'Reilly, R. J.; Sadelain, M.; Kernan, N. A.; Brentjens, R. J.; Riviere, I.
    Blood (2010)

    Fulltext@MSK | Save
  • Paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patients: Review of a single center series
    Meeting Abstract

    Curran, K. J.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Castro-Malaspina, H.; Araten, D.; DiMichele, D.; O'Reilly, R. J.; Boulad, F.
    Blood (2010)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of children with very high risk (VHR) acute lymphoblastic leukemia (ALL) in first remission (CR1)
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Steinherz, P. G.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Kobos, R.; Shukla, N.; Doorish, C.; O'Reilly, R. J.
    Blood (2010)

    Fulltext@MSK | Save
  • A phase I-II dose escalation trial of clofarabine plus melphalan and thiotepa followed by unmodified allogeneic stem cell transplant (SCT) for the treatment of high risk or advanced acute leukemia
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Klein, E. G.; Barker, J.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Blood (2010)

    Fulltext@MSK | Save